Revvity | سود عملیاتی



Operating Profit تغییر دادن تاریخ
Adcock Ingram Holdings ZAR 479.08M 106.67M 2024-06
Agilent USD 376M 32M 2025-01
Align Technology USD 144.15M 18.15M 2024-12
Bio Techne USD 47.42M 7.43M 2024-12
Bio-Rad Laboratories USD 58.4M 6.07M 2024-12
Bruker USD 64.1M 4M 2024-12
Celltrion KRW 207.69B 135.2B 2024-09
Charles River Laboratories USD -167687000 285.09M 2024-12
Cspc Pharmaceutical CNY 985M 796.94M 2024-09
Danaher USD 1.42B 467M 2024-12
Dentsply International USD -509000000 47M 2024-12
Dianthus Therapeutics USD -29900000 7.7M 2024-09
Ecofibre AUD -4680000 38.98M 2024-06
Edwards Lifesciences USD 312.6M 38M 2024-12
Exact Sciences USD -876351000 836.95M 2024-12
Hologic USD 229.8M 200K 2024-12
Illumina USD 175M 566M 2024-12
Intuitive Surgical USD 734.9M 157.6M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
Kangmei Pharma CNY -58945310 67.51M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 37.16M 17.88M 2024-06
Laboratory Of America USD 216.5M 37.6M 2024-12
Malin Corporation EUR -700000 1.6M 2024-06
Medical Developments International AUD -20243000 7.24M 2024-06
Mettler Toledo International USD 314.55M 295.95M 2024-12
Myriad Genetics USD -39000000 19M 2024-12
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Patterson Companies USD 45.44M 7.8M 2025-01
Pharma Mar EUR 4.89M 588K 2024-12
Qiagen NV USD 144.16M 14.73M 2024-12
Quest Diagnostics USD 361M 8M 2024-12
Quidel USD -100400000 115.4M 2024-12
Repligen USD -7830000 10.29M 2024-09
Revvity USD 118.75M 20.6M 2024-12
Sartorius EUR 68.2M 38.1M 2024-09
Sino Biopharmaceutical CNY 1.73B 948.23M 2024-06
Thermo Fisher Scientific USD 2.02B 178M 2024-12
Tilray USD -42218000 5.65M 2024-11
Waters USD 292.26M 81.13M 2024-12
Zz Pientze Pharmaceu 1.13B 233.14M 2024-09



Revvity سود عملیاتی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2025.